$FOLD·4

AMICUS THERAPEUTICS INC · Jun 23, 8:09 PM ET

AMICUS THERAPEUTICS INC 4

4 · AMICUS THERAPEUTICS INC · Filed Jun 23, 2015

Insider Transaction Report

Form 4
Period: 2015-06-19
Dilone Enrique
VP, Technical Operations
Transactions
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-06-191,89631,208 total
    Exercise: $4.38From: 2013-06-04Exp: 2022-06-04Common stock (1,896 underlying)
  • Exercise/Conversion

    Common stock

    2015-06-19$13.26/sh+14,045$186,27544,733 total
  • Sale

    Common stock

    2015-06-19$13.26/sh14,045$186,27530,688 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-06-193,2506,500 total
    Exercise: $4.16From: 2013-11-01Exp: 2019-11-16Common Stock (3,250 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-06-192,62422,752 total
    Exercise: $3.53From: 2014-01-28Exp: 2023-01-28Common stock (2,624 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-06-193,46328,074 total
    Exercise: $2.52From: 2014-06-18Exp: 2023-06-18Common stock (3,463 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-06-192,81239,376 total
    Exercise: $2.45From: 2015-01-03Exp: 2024-01-03Common stock (2,812 underlying)
Footnotes (3)
  • [F1]The exercise of stock options and subsequent sales of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
  • [F2]This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.16 to $13.33. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.16 to $13.33. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION